Email UpdatesThe article discusses the new FDA approval for the first nalmefene hydrochloride auto-injector for emergent treatment of a suspected opioid overdose.
Source
U.S. Food and Drug Administration (FDA)
Year
Format
Terms of Use
Topic
Audience
Resource Type
Use
Special Collection